Darifenacin hydrobromide
Darifenacin hydrobromide (UK-88525) is a selective M3 muscarinic receptor antagonist. It is widely used in pharmacological research to study overactive bladder syndrome, with applications in both in vitro receptor binding assays and in vivo models of urinary incontinence.
Product Specifications
CAS Number
133099-07-7
Product Name Alternative
Darifenacin, Darifenacin HBr, Darifenacin hydrobromide, Darifenacin Hydrobromide, Muscarinic acetylcholine receptor, inhibit, mAChR, M3 mAChR, Inhibitor, UK 88525, UK88525, UK-88525
Field of Research
Neuroscience, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.71% (May vary between batches)
Solubility
DMSO:93 mg/mL (183.99 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.53 mM)
Smiles
C1cccc (c1) C (c1ccccc1) ([C@H]1CN (CC1) CCc1cc2c (cc1) OCC2) C (=O) N.Br
Molecular Formula
C28H31BrN2O2
Molecular Weight
505.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR219252L4 10 µg
Themis2 (NM_001033308) Mouse Tagged Lenti ORF Clone
Sign In for Pricing
View Details abx073884-01 2 µg
Human Vascular Endothelial Growth Factor Receptor 3 (FLT4) Enzyme
Sign In for Pricing
View Details